Chinese equipment maker based in Wuxi; exact product scope (imaging/inspection equipment) not independently confirmed.
Chinese equipment maker based in Wuxi; exact product scope (imaging/inspection equipment) not independently confirmed.
Moat: none
Headquarters: Wuxi, Jiangsu, China · Employees: 1,302
Size Wuxi Unicomp Technology (688531.SS) is a China Health Care company (Medical Specialties) with a market value of $1.58B, the 1452nd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥68.48 on 18 Nov 2026.
Performance Over six months the shares fell 48.8%, against +1.9% for the median peer and -20.0% for the China market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 53.0% over the last twelve months (peer median +6.6%); the operating margin is 11.8% (peer median 8.2%).
Valuation It trades at 35.8× forward earnings against a peer median of 22.0× (5th most expensive of 18).
Capital Return on invested capital runs 11.3 points below its cost of capital (16.4% WACC).
Next results Next results expected around 3 May 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.48B | CN¥1.07B | CN¥736M | CN¥585M | CN¥485M |
| Revenue growth | — | +46% | +26% | +21% | — |
| Gross profit | CN¥678M | CN¥448M | CN¥307M | CN¥214M | n/a |
| EBITDA | n/a | CN¥163M | CN¥102M | CN¥62.0M | n/a |
| Net income | CN¥248M | CN¥176M | CN¥143M | CN¥114M | CN¥71.7M |
| Free cash flow | -CN¥167M | -CN¥102M | -CN¥151M | -CN¥90.8M | n/a |
| Capital expenditure | CN¥396M | CN¥334M | CN¥225M | CN¥121M | CN¥0 |
| Total debt | CN¥370M | CN¥275M | CN¥119M | CN¥118M | CN¥0 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Wuxi Unicomp Technology 688531.SS | $1.58B | -49% | +53% | 12% | 35.8× | n/a |
| COMET COTN.SW | $2.78B | -15% | -3% | 6% | 32.8× | n/a |
| Nordson NDSN | $18.0B | +17% | +7% | 27% | 25.5× | 16.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688531.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -34.4% | -0.1% | lowest of 21 |
| 6-month return | -48.8% | +1.9% | lowest of 21 |
| Distance from 52-week high | -68.2% | -24.8% | lowest of 21 |
| Revenue growth (TTM) | +53.0% | +6.6% | 3rd highest of 21 |
| Operating margin | 11.8% | 8.2% | 9th highest of 21 |
| Forward P/E | 35.8× | 22.0× | 5th most expensive of 18 |
| ROIC minus cost of capital | -11.3 pp | +2.3 pp | 4th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Wuxi Unicomp Technology 688531.SS | China | $1.58B | -49% | +53% | 12% | 35.8× | n/a | n/a |
| Vitrolife VITR.ST | Sweden | $1.57B | +13% | -2% | 19% | 27.0× | 22.2% | +22.5% |
| Enovis ENOV | United States | $1.56B | +2% | +3% | 4% | 7.6× | 20.0% | -6.0% |
| Cofoe Medical Technology 301087.SZ | China | $1.60B | -6% | +33% | 10% | 25.1× | 11.2% | +7.4% |
| Nihon Kohden 6849.T | Japan | $1.55B | +3% | 0% | 7% | 18.8× | -3.5% | +3.3% |
| Shanghai MicroPort Endovascular MedTech 688016.SS | China | $1.55B | -19% | +16% | 44% | 16.4× | 2.7% | +23.4% |
| Angelalign Technology 6699.HK | Hong Kong | $1.62B | -8% | +84% | 9% | 52.5× | 16.7% | +25.8% |
| Butterfly Network BFLY | United States | $1.63B | +38% | +39% | -36% | n/a | n/a | n/a |
| NIPRO 8086.T | Japan | $1.68B | -11% | +5% | 5% | 15.8× | n/a | n/a |
| Inspire Medical Systems INSP | United States | $1.68B | +32% | 0% | 2% | 41.3× | 28.7% | +51.2% |
| Kestra Medical Technologies KMTS | United States | $1.69B | +36% | +61% | -134% | n/a | n/a | n/a |
| DENTSPLY SIRONA XRAY | United States | $1.69B | -13% | -1% | 5% | 6.8× | 11.2% | +1.9% |
| El.En ELN.MI | Italy | $1.46B | +11% | +3% | 15% | 22.0× | 10.7% | +7.7% |
| Inner Mongolia Furui Medical Science 300049.SZ | China | $1.45B | -31% | +11% | 25% | 41.9× | 2.9% | +14.6% |
| Embla Medical hf EMBLA.CO | Denmark | $1.72B | +1% | +6% | 14% | 17.2× | -1.9% | +8.3% |
| Sinocare 300298.SZ | China | $1.45B | +4% | +7% | 6% | 21.5× | 9.5% | +18.3% |
| Mehow Innovative 301363.SZ | China | $1.72B | -36% | +10% | 21% | 34.2× | 16.4% | +12.9% |
| PROCEPT BioRobotics PRCT | United States | $1.45B | -10% | +17% | -34% | n/a | n/a | n/a |
| LeMaitre Vascular LMAT | United States | $1.73B | -25% | +12% | 28% | 24.5× | 2.9% | +14.0% |
| CONMED CNMD | United States | $1.43B | +30% | +2% | 2% | 10.4× | 31.6% | +9.8% |
| ChemoMetec A/S CHEMM.CO | Denmark | $1.77B | +107% | +3% | 49% | 46.7× | 19.4% | +12.7% |